Skip to content
Profiles

Klaus-Armin Nave, PhD

Max Planck Institute of Experimental Medicine
Göttingen, Germany

Klaus-Armin Nave works on the generation, characterization, and preclinical studies of a transgenic rat model of CMT1A. NRG1-ErbB signaling in the PNS. Glial metabolic support to axon function.

Man in a blue shirt and dark blue sport coat, sitting in front of a medical microscope

Joined

2015

Therapy Type

Small Molecule

CMT1A